Bgb-A425, an investigational anti-TIM-3 monoclonal antibody, in combination with tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: A phase I/II trial in progress.

Jayesh Desai, Tarek Meniawy, Brandon Beagle, ZheZhen Li, Song Mu, John Wu, Crystal S. Denlinger, Wells A. Messersmith

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

5 Citations (Web of Science)
Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2020
Event56th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -
Duration: 29 May 202031 May 2020

Cite this